404
+1-313-307-4176
sales@stratviewresearch.com
Heart Blocks Treatment Devices Market Report
Heart Blocks Treatment Devices Market Size, Share, Trend, Forecast, & Industry Analysis: 2022-2028
The Heart Blocks Treatment Devices Market is estimated to grow from USD 2.95 billion in 2021 to USD 4.25 billion by 2028 at a healthy CAGR of 5.28% during the forecast period of 2022-2028.
Heart blocks are also referred to as atrioventricular (AV) blocks which is a condition, in which the electric signals that control the heartbeat are fairly or completely blocked from reaching the ventricles. Different devices that can be used to treat heart blocks comprise a pacemaker that uses electric signals to normalize heartbeat at a standard rate.
The rapidly growing incidence of cardiovascular disease is one of the major factors intensifying the growth and demand of heart blocks treatment devices market in the coming years. Moreover, the increasing number of geriatric inhabitants around the world is also influencing the market growth. Also, the development of pacemakers and minimally invasive cardiovascular treatment coupled with the rapidly changing standard of living are also improving the growth of the market growth during the forecast period.
The COVID-19 outbreak positively influenced the growth of the heart blocks treatment devices market. Rising cases of coronavirus across the globe put a heavy strain on the healthcare sector. Rise in heart patients and cardiovascular diseases and as they are highly prone to get infected by COVID-19, there is strong growth of heart blocks treatment devices during the pandemic.
Key players operating in the heart blocks treatment devices market are-
Here is the list of the group of customers that the heart blocks treatment devices market hopes to have the greatest opportunity to convert-
Based on Product, the market has been classified into transcutaneous pacing, pacemaker, mediation, and follow-up electrophysiology study. The pacemaker segment accounted for a substantial market share in 2021. Growing incidences of Cardiovascular Diseases (CVDs), increasing cost of cardiac disease management, favorable government policies, and the emergence of technologically advanced pacemakers such as leadless pacemakers and MRI safe pacemakers, further bolster the segment growth.
The market in North America accounted for the largest share in 2021 and is projected to continue its dominance during the review period. This is mainly attributed to the strong presence of well-developed healthcare infrastructure, increasing investment in R&D activities, higher adoption of these technologies, and favorable government initiatives. Moreover, the favorable reimbursement policies, high rate of R&D activities, easy availability of advanced technology, and enhanced patient knowledge within the region, further proliferates the regional growth.
The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
|
Report Feature |
|
|---|---|
|
Market Segmentation |
4 |
|
Regions Covered |
5 |
|
Countries/Subregions Covered |
16 |
|
Figures & Tables |
>90 |
|
Company Profile |
10 |
The market is segmented into the following categories.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Current market segmentation of any one of the product types by application type.
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.
The heart blocks treatment devices market is expected to witness an impressive growth of 5.28% CAGR in the coming years.
Medtronic (US), Abbott (US), MicroPort Scientific Corporation (China), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (US), LivaNova PLC (UK), Lepu Medical Technology (Beijing) Co., Ltd. (China), McKesson Corporation, Stryker, and SCHILLER (Switzerland) are among the key players in the heart blocks treatment devices market.
The heart blocks treatment devices market size is expected to reach USD 4.25 billion in 2028.
The pacemaker segment accounted for the substantial share in the heart blocks treatment market in 2021.
North America is expected to remain dominant in the heart blocks treatment market in the next five years.
Heart Blocks Treatment Devices distributors, Heart Blocks Treatment Devices suppliers, Heart Blocks Treatment Devices manufacturers, Hospitals, Government bodies are the target audience in the heart block treatment market.
WE ACCEPT
